NL-OMON26213
Not yet recruiting
Not Applicable
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.
VU university medical center0 sites224 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- VU university medical center
- Enrollment
- 224
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with malignant hematological diseases being treated with cytotoxic chemotherapy or stem cell transplantation;
- •2\. High\-risk neutropenia;
Exclusion Criteria
- •1\. Contraindications to use of imipenem\-cilastatin or meropenem such as allergy, previous severe side\-effects or previous microbiological cultures with carbapenem\-resistant microorganism(s).
- •2\. Corticosteroid use ≥10 mg per day prednisolone or equivalent during the previous 7 days.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trialinfective endocarditisTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2019-003358-10-ESCarmen Olmos Blanco298
Active, not recruiting
Phase 1
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2014-001546-25-NLVU University Medical Center240
Completed
Phase 4
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.febrile neutropenia1001886510004018NL-OMON47609VUmc276
Terminated
Phase 3
Short or Long Schemes of Antibiotic Prophylaxis for Prostate BiopsyMen Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.NCT00294749Poitiers University Hospital300
Completed
Phase 3
Duration of Antibiotic Therapy in the Treatment of Severe Postoperative Peritonitis Admitted in ICUPostoperative PeritonitisNCT01311765Assistance Publique - Hôpitaux de Paris244